Pure H20 Bio-Technologies, Inc. (OTCBB:PHBT) today announced Khandaker Partners, Inc., a New York, N.Y. Equity Research Firm, initiated coverage of Pure H20 Bio-Technologies, Inc. The following Khandaker Equity Research Report is for marketing purposes and consumer awareness. Its content is a based overview report by Khandaker's Medical Doctors who are senior analysts, leaving a transparent unbiased company overview based on merit. Pure H20 Bio-Technologies, Inc., will be enrolled on Khandaker Analytical Review in the near future as it is the premiere investment and business online forum for Health Care, Life Sciences, and Medical Technology. Pure H20 Bio-Technologies will be featured on Khandaker.com along with product profile and investor information that will be maintained on "Investor Central" for the year 2005. Updated postings of all company press releases will also be viewed on Khandaker.com.
